Terry Smith’s Fundsmith Equity just dumped this FTSE 100 flop! Should I sell too?

Ben McPoland wonders whether he should follow one of the UK’s star fund managers by selling this disappointing FTSE 100 laggard.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Terry Smith doesn’t tend to hold too many FTSE 100 shares in his £23.9bn Fundsmith Equity portfolio. He has even less now after disposing of his Diageo (LSE: DGE) holding last month.

By contrast, I added to my holding in August. Should I reverse that decision? Here are my thoughts.

Pick a reason

Now, the first thing to say is that we don’t know why Fundsmith sold the spirits giant. Its latest factsheet simply states: “We exited our position in Diageo during the month“.

But there isn’t any shortage of potential reasons. The share price is down 14.5% year to date and 39% since late 2021. It’s turned into a serial underperformer.

Last year (FY24), the company saw declining volumes, sales and earnings. There was an embarrassing buildup of unsold booze in Latin America, which raised questions about its inventory management.

Looking ahead, the firm has also warned that FY25 is going to be challenging. Its medium-term 5-7% annual organic growth target now seems to be on the rocks (or at least on ice).

I reckon there’s enough in all that to turn Smith bearish. But perhaps he also worries that Gen-Z is drinking less. Non-alcoholic cocktails are on the rise.

Meanwhile, there’s evidence that weight-loss drugs like Wegovy and Zepbound are reducing demand for spirits. According to research from Morgan Stanley, between 56% and 62% of alcohol consumers on these medications reported drinking less. Around 14% to 18% said they’d cut out booze altogether!

These trends are particularly pronounced in North America, where Diageo generates 39% of net sales.

Share of reported FY24 net sales by region (%)

Source: Diageo FY 2024 annual report

I’m not selling yet

Writing all that, I feel like whipping out my phone and dumping my Diageo shares too!

The reason I won’t is because I believe Diageo’s current weakness is cyclical, not structural. In other words, I still anticipate significant future demand for the firm’s premium brands.

It has a boatload of these. In whisky, it owns Johnnie Walker, Crown Royal, Bulleit, and Buchanan’s. In vodka, Smirnoff, Cîroc, and Ketel One. In tequila, Don Julio and Casamigos.

Some of its brands, such as Guinness and Baileys, are essentially in a category of their own.

Plus, despite its annus horribilis, the firm still managed to make nearly $6bn in operating profit. And it generated $2.6bn of free cash flow, up $400m on the previous year. I’ve seen far worse from struggling businesses recently.

There’s also a dividend that now yields 3.4% on a forward-looking basis. Nothing’s certain with dividends, but I think the payout could continue rising steadily for decades to come.

Finally, the shares are currently valued on 17.7 prospective earnings. I believe that’s a pretty attractive valuation, which is why I recently added a few more shares to my portfolio.

Some things change slowly

Despite what I occasionally read, I’m skeptical that certain things — cigarettes, oil, fast food, booze — are facing imminent existential threats.

The world population is growing rapidly and many people are going to get a lot richer in future. Whether in hotels, restaurants, cocktail bars or airports, Diageo’s timeless brands will still be there waiting for them.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in Diageo Plc. The Motley Fool UK has recommended Diageo Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »